Trinity Biotech (TRIB)
NASDAQ: TRIB
· Real-Time Price · USD
1.63
-0.28 (-14.66%)
At close: Aug 15, 2025, 3:59 PM
1.50
-7.98%
After-hours: Aug 15, 2025, 06:40 PM EDT
Trinity Biotech Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 61.56M | 59.13M | 58.65M | 56.71M | 56.83M | 61.44M | 66.27M | 70.83M | 74.78M | 76.27M | 78.77M | 86.15M | 92.97M | 106.21M | 116.22M | 106.4M |
Cost of Revenue | 40.64M | 38.98M | 39.54M | 38.3M | 37.84M | 40.32M | 47.41M | 50.48M | 52.73M | 53.22M | 48.83M | 51.71M | 54.89M | 59.71M | 61.84M | 56.18M |
Gross Profit | 20.91M | 20.14M | 19.12M | 18.41M | 18.99M | 21.12M | 18.85M | 20.35M | 22.05M | 23.05M | 29.94M | 34.44M | 38.08M | 46.5M | 54.37M | 50.22M |
Operating Income | -21.19M | -13.17M | -15.11M | -25.91M | -26.76M | -28.05M | -28.35M | -15.01M | -21.27M | -17.75M | -10.2M | -2.4M | 10.86M | 21.18M | 27.52M | 21.73M |
Interest Income | 903K | 903K | 444K | 506K | 605K | 717K | 657K | 595K | 659K | 547K | 412K | 413K | 196K | 196K | 5K | 6K |
Pretax Income | -30.73M | -20.44M | -22.14M | -33.87M | -36.93M | -41.52M | -43.96M | -45.44M | -41.2M | -30.62M | -20.13M | 5.05M | 8.99M | 16.35M | 22.67M | 16.87M |
Net Income | -31.79M | -20.34M | -22.3M | -21.53M | -24.52M | -29.09M | -31.31M | -45.39M | -41M | -29.25M | -18.99M | 289K | 3.81M | -7.88M | -1.88M | -2.56M |
Selling & General & Admin | 28.29M | 26.39M | 27.56M | 29.04M | 30.7M | 34.41M | 32.52M | 31.67M | 29.17M | 24.31M | 24.66M | 24.19M | 24.45M | 26.27M | 26.57M | 25.2M |
Research & Development | 4.54M | 4.21M | 4.37M | 4.61M | 4.38M | 4.43M | 4.28M | 4.03M | 4.14M | 3.91M | 3.95M | 4.03M | 4.5M | 4.84M | 5.04M | 5.14M |
Other Expenses | 9.28M | 2.71M | 2.37M | n/a | n/a | -341K | -342K | -341K | -342K | -723K | -1.76M | -4.67M | -4.67M | -5.79M | -4.75M | -1.85M |
Operating Expenses | 42.11M | 33.31M | 34.23M | 33.51M | 34.94M | 38.35M | 36.38M | 35.36M | 32.97M | 27.5M | 26.84M | 23.54M | 24.28M | 25.32M | 26.86M | 28.49M |
Interest Expense | 11.96M | 7.91M | 7.21M | 8.2M | 10.49M | 11.16M | 10.95M | 15.43M | 15.12M | 16.2M | 15.38M | 8.28M | 7.25M | 5.64M | 5.5M | 5.51M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 82.75M | 72.3M | 73.76M | 71.8M | 72.78M | 78.67M | 83.8M | 85.84M | 85.69M | 80.72M | 75.68M | 75.25M | 79.17M | 85.03M | 88.7M | 84.67M |
Income Tax Expense | 486K | -102K | 155K | 19K | -59K | -72K | -291K | -54K | -193K | -1.36M | -1.11M | -421K | -166K | 290K | 417K | -206K |
Shares Outstanding (Basic) | 14.17M | 10.39M | 9.47M | 8.87M | 7.64M | 7.67M | 7.66M | 7.63M | 7.62M | 7.62M | 5.9M | 5.9M | 4.18M | 4.18M | 4.18M | 4.18M |
Shares Outstanding (Diluted) | 14.17M | 10.39M | 9.47M | 8.87M | 7.67M | 7.67M | 7.66M | 7.63M | 7.62M | 7.62M | 6.44M | 6.44M | 5.25M | 4.37M | 4.18M | 4.53M |
EPS (Basic) | -2.8 | -2.2 | -2.6 | -2.8 | -3.2 | -3.8 | -4 | -6.8 | -6.2 | -4.4 | -3.2 | -0.05 | 0.35 | -2.4 | -2.2 | -2.4 |
EPS (Diluted) | -2.8 | -2.2 | -2.6 | -2.8 | -3.2 | -3.8 | -4 | -6.6 | -6 | -4.4 | -3.2 | -0.11 | 0.26 | -1.94 | -1.72 | -1.81 |
EBITDA | -16.9M | -10.33M | -13.1M | -23.51M | -24.38M | -28.38M | -30.51M | -17.38M | -14.55M | -12.86M | -4.3M | 4.16M | 8.11M | 2.24M | 9.48M | 3.5M |
EBIT | -18.77M | -12.86M | -15.26M | -26M | -26.78M | -30.36M | -34.05M | -21.11M | -18.35M | -16.55M | -7M | 1.13M | 5.21M | -85K | 7.25M | 1.47M |
Depreciation & Amortization | 1.87M | 1.9M | 1.53M | 1.87M | 1.78M | 1.98M | 2.5M | 2.27M | 2.37M | 3.65M | 3.71M | 4.44M | 4.54M | 3.58M | 3.48M | 3.28M |